[go: up one dir, main page]

NO770804L - Analogifremgangsm}te for fremstilling av terapeutisk aktive aminoalyl-heterocykliske forbindelser - Google Patents

Analogifremgangsm}te for fremstilling av terapeutisk aktive aminoalyl-heterocykliske forbindelser

Info

Publication number
NO770804L
NO770804L NO770804A NO770804A NO770804L NO 770804 L NO770804 L NO 770804L NO 770804 A NO770804 A NO 770804A NO 770804 A NO770804 A NO 770804A NO 770804 L NO770804 L NO 770804L
Authority
NO
Norway
Prior art keywords
aminoalyl
preparation
therapeutically active
heterocyclic compounds
analogical procedure
Prior art date
Application number
NO770804A
Other languages
English (en)
Other versions
NO147950C (no
NO147950B (no
Inventor
Anton Mentrup
Kurt Schromm
Ernst-Otto Renth
Richard Reichl
Werner Traunecker
Wolfgang Hoefke
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO770804L publication Critical patent/NO770804L/no
Publication of NO147950B publication Critical patent/NO147950B/no
Publication of NO147950C publication Critical patent/NO147950C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/36One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Laminated Bodies (AREA)
  • Nonwoven Fabrics (AREA)
NO770804A 1976-03-09 1977-03-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoalkyl-heterocykliske forbindelser NO147950C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762609645 DE2609645A1 (de) 1976-03-09 1976-03-09 Aminoalkylheterocyclen

Publications (3)

Publication Number Publication Date
NO770804L true NO770804L (no) 1977-09-12
NO147950B NO147950B (no) 1983-04-05
NO147950C NO147950C (no) 1983-07-13

Family

ID=5971857

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770804A NO147950C (no) 1976-03-09 1977-03-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoalkyl-heterocykliske forbindelser

Country Status (36)

Country Link
US (4) US4154829A (no)
JP (2) JPS52108970A (no)
AT (1) AT360542B (no)
AU (1) AU515953B2 (no)
BE (1) BE852223A (no)
BG (4) BG28051A4 (no)
CA (1) CA1086317A (no)
CH (8) CH630358A5 (no)
CS (2) CS209435B2 (no)
DD (1) DD130037A5 (no)
DE (1) DE2609645A1 (no)
DK (1) DK102177A (no)
ES (10) ES456622A1 (no)
FI (1) FI69070C (no)
FR (2) FR2343731A1 (no)
GB (1) GB1571231A (no)
GR (1) GR64553B (no)
HK (1) HK12884A (no)
HU (1) HU177953B (no)
IE (1) IE45300B1 (no)
IL (1) IL51627A (no)
LU (1) LU76898A1 (no)
MX (1) MX4878E (no)
MY (1) MY8500079A (no)
NL (1) NL7702403A (no)
NO (1) NO147950C (no)
NZ (1) NZ183536A (no)
PH (3) PH16110A (no)
PL (2) PL111240B1 (no)
PT (1) PT66282B (no)
RO (3) RO79706A (no)
SE (1) SE435059B (no)
SG (1) SG55583G (no)
SU (4) SU698530A3 (no)
YU (1) YU62377A (no)
ZA (1) ZA771412B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
PT71175A (fr) 1979-05-04 1980-05-01 Continental Pharma Procede pour preparer derives de benzimidazoles
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3325875A1 (de) * 1983-07-18 1985-01-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
TW203049B (no) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6075040A (en) * 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
EP0827746B1 (en) 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
CN1516584A (zh) 2001-04-18 2004-07-28 ŷ�����ǹɷ����޹�˾ 螺吡唑化合物
SI1385518T1 (sl) 2001-04-18 2009-02-28 Euro Celtique Sa Benzimidazolonske spojine
RU2265018C2 (ru) * 2001-04-18 2005-11-27 Эро-Селтик, С.А. Производные бензимидазола и фармацевтические композиции на их основе
EP2033644A1 (en) 2001-04-18 2009-03-11 Euro-Celtique S.A. Spiroindene and spiroindane compounds
CA2444198C (en) 2001-04-18 2010-06-22 Euro-Celtique, S.A. Nociceptin analogs
AU2002303406B2 (en) * 2001-04-18 2006-03-30 Euro-Celtique S.A. Nociceptin analogs
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
MXPA05005661A (es) * 2002-11-27 2005-11-23 Artesian Therapeutics Inc Compuestos con actividad antagonista o antagonista parcial mixta inhibidora de fosfodiesterasa y beta-adrenergica para el tratamiento de insuficiencia cardiaca.
WO2004058726A2 (en) * 2002-12-23 2004-07-15 Artesian Therapeutics, Inc. CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
DE102004001413A1 (de) * 2004-01-09 2005-08-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
DE102004021779A1 (de) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
JP2008521805A (ja) * 2004-11-30 2008-06-26 アーテシアン セラピューティクス, インコーポレイテッド β−アドレナリン作用性受容体およびホスホジエステラーゼに対する阻害活性を有する強心性化合物
WO2006060127A2 (en) * 2004-11-30 2006-06-08 Artesian Therapeutics, Inc. COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
DE102005007654A1 (de) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
MX2008001976A (es) * 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
DE102005052127A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052102A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052101A1 (de) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
JP2009526817A (ja) * 2006-02-16 2009-07-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療用医薬組成物
PE20080142A1 (es) 2006-03-15 2008-04-14 Boehringer Ingelheim Int Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion
WO2008017637A1 (de) 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
WO2009026227A2 (en) * 2007-08-16 2009-02-26 The University Of Mississippi Highly selective sigma receptor ligands
US9604926B2 (en) 2007-08-16 2017-03-28 The University Of Mississippi Highly selective sigma receptor radioligands
US8686008B2 (en) * 2007-08-16 2014-04-01 The University Of Mississippi Highly selective sigma receptor ligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA631296A (en) * 1961-11-21 L. Clark Robert Substituted benzimidazolones
CH149009A (de) * 1929-08-10 1931-08-15 Chem Ind Basel Verfahren zur Darstellung einer N-substituierten Verbindung der Pyridonreihe.
US2857394A (en) * 1957-05-10 1958-10-21 Ciba Pharm Prod Inc Heterocyclic compounds
NL284529A (no) * 1961-10-24
FR1516714A (fr) * 1962-11-07 1968-02-05 Bayer Ag Procédé de préparation de dérivés de l'imidazolidine
FR1384708A (fr) * 1963-11-21 1965-01-08 Thomson Houston Comp Francaise Perfectionnements aux dispositifs de mise en place d'objets
BE659364A (no) * 1964-02-05
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
FR1573739A (no) * 1968-07-26 1969-07-04
US3984405A (en) * 1971-06-28 1976-10-05 E. R. Squibb & Sons, Inc. Anti-inflammatory agents
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
FR2168140A1 (en) * 1972-01-17 1973-08-31 Bellon Labor Sa Roger Dihydro-benzoxazine derivs - antidepressants
US3925383A (en) * 1972-12-08 1975-12-09 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
AU515953B2 (en) 1981-05-14
FR2372810B1 (no) 1982-11-26
SU698530A3 (ru) 1979-11-15
ES466602A1 (es) 1978-10-01
CH630360A5 (de) 1982-06-15
IL51627A (en) 1980-10-26
DK102177A (da) 1977-09-10
BG27743A3 (bg) 1979-12-12
BG28052A4 (bg) 1980-02-25
JPS52108970A (en) 1977-09-12
ES466598A1 (es) 1978-10-01
ATA122377A (de) 1980-06-15
CS209435B2 (en) 1981-12-31
NO147950C (no) 1983-07-13
US4363814A (en) 1982-12-14
IL51627A0 (en) 1977-05-31
SE7702609L (sv) 1977-10-11
US4154829A (en) 1979-05-15
IE45300B1 (en) 1982-07-28
FR2343731B1 (no) 1982-02-26
DD130037A5 (de) 1978-03-01
PH17635A (en) 1984-10-18
CS220320B2 (en) 1983-03-25
NO147950B (no) 1983-04-05
FI770586A7 (no) 1977-09-10
AT360542B (de) 1981-01-12
LU76898A1 (no) 1978-06-01
PT66282B (pt) 1979-01-17
FR2372810A1 (fr) 1978-06-30
ES456622A1 (es) 1978-03-16
SU683616A3 (ru) 1979-08-30
US4215119A (en) 1980-07-29
CH630365A5 (de) 1982-06-15
JPS6172A (ja) 1986-01-06
PL112937B1 (en) 1980-11-29
PL196505A1 (pl) 1979-06-18
NL7702403A (nl) 1977-09-13
ES466605A1 (es) 1978-10-01
RO76589A (ro) 1981-04-30
SG55583G (en) 1984-07-27
CH630358A5 (de) 1982-06-15
HK12884A (en) 1984-02-24
ZA771412B (en) 1978-11-29
GB1571231A (en) 1980-07-09
SU685149A3 (ru) 1979-09-05
PT66282A (pt) 1977-04-01
GR64553B (en) 1980-04-14
RO79706A (ro) 1982-08-17
FI69070C (fi) 1985-12-10
CH630361A5 (de) 1982-06-15
CH630359A5 (de) 1982-06-15
FI69070B (fi) 1985-08-30
ES466600A1 (es) 1978-10-01
CA1086317A (en) 1980-09-23
US4271158A (en) 1981-06-02
IE45300L (en) 1977-09-09
MY8500079A (en) 1985-12-31
CH630364A5 (de) 1982-06-15
ES466603A1 (es) 1978-10-01
AU2300977A (en) 1978-09-14
ES466601A1 (es) 1978-10-01
BG28051A4 (bg) 1980-02-25
PL111240B1 (en) 1980-08-30
CH630362A5 (de) 1982-06-15
MX4878E (es) 1982-11-26
SU676163A3 (ru) 1979-07-25
BE852223A (fr) 1977-09-08
CH630363A5 (de) 1982-06-15
HU177953B (en) 1982-02-28
PH16149A (en) 1983-07-12
SE435059B (sv) 1984-09-03
BG28053A4 (bg) 1980-02-25
ES466606A1 (es) 1978-10-01
ES466604A1 (es) 1978-10-01
NZ183536A (en) 1981-11-19
ES466599A1 (es) 1978-10-01
YU62377A (en) 1982-10-31
PH16110A (en) 1983-06-30
RO70569A (ro) 1981-11-24
FR2343731A1 (fr) 1977-10-07
DE2609645A1 (de) 1977-09-15

Similar Documents

Publication Publication Date Title
NO770804L (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive aminoalyl-heterocykliske forbindelser
NO823274L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme bis-pyridiniumalkanforbindelser
NO773384L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO780883L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer
SE431646B (sv) Forfarande for framstellning av acylaminosubstituerade femledade heterocykliska kveveforeningar
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO781880L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO150605C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinyl-aminoalkyletere
NO150081C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme derivater av perhydro-aza-heterocykler
NO792139L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater
NO834363L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater
NO772329L (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive imidazolinderivater
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
SE433081B (sv) Forfarande for framstellning av cefalosporinforeningar
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater